TJ294B - Method for selective methionine starvation of malignant cells in mammals - Google Patents
Method for selective methionine starvation of malignant cells in mammalsInfo
- Publication number
- TJ294B TJ294B TJ96000320A TJ96000320A TJ294B TJ 294 B TJ294 B TJ 294B TJ 96000320 A TJ96000320 A TJ 96000320A TJ 96000320 A TJ96000320 A TJ 96000320A TJ 294 B TJ294 B TJ 294B
- Authority
- TJ
- Tajikistan
- Prior art keywords
- malignant cells
- mammal
- mtase
- mammals
- methionine
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/88—Lyases (4.)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/51—Lyases (4)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
- A61K47/60—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes the organic macromolecular compound being a polyoxyalkylene oligomer, polymer or dendrimer, e.g. PEG, PPG, PEO or polyglycerol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/527—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving lyase
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Genetics & Genomics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Epidemiology (AREA)
- Biotechnology (AREA)
- Physics & Mathematics (AREA)
- Biomedical Technology (AREA)
- Gastroenterology & Hepatology (AREA)
- Analytical Chemistry (AREA)
- Biophysics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Enzymes And Modification Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Compounds Of Unknown Constitution (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
An improved method for chemotherapy of mammalian malignant cells which have an absolute requirement for methionine but lack methylthioadenosine phosphorylase (MTAse). The method comprises detection of MTAse negative cells in a mammal, administration of methionine gamma -lyase in sufficient amounts to reduce the volume of MTAse negative cells in the mammal, and co-administration of methylthioadenosine in amounts sufficient to ensure the continued availability of methionine to the mammal's non-malignant cells. Means for detection of MTAse negative cells are provided. Means for production and use of recombinant chemotherapeutic agents are also provided.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/176,413 US5571510A (en) | 1993-12-29 | 1993-12-29 | Method for selective methionine starvation of malignant cells in mammals |
PCT/US1994/014919 WO1995017908A1 (en) | 1993-12-29 | 1994-12-22 | Method for selective methionine starvation of malignant cells in mammals |
Publications (1)
Publication Number | Publication Date |
---|---|
TJ294B true TJ294B (en) | 2001-03-30 |
Family
ID=22644262
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TJ96000320A TJ294B (en) | 1993-12-29 | 1994-12-22 | Method for selective methionine starvation of malignant cells in mammals |
Country Status (17)
Country | Link |
---|---|
US (1) | US5571510A (en) |
EP (1) | EP0805690B1 (en) |
JP (1) | JPH09507754A (en) |
CN (1) | CN1143325A (en) |
AT (1) | ATE221785T1 (en) |
AU (1) | AU694161B2 (en) |
CA (1) | CA2180262A1 (en) |
CZ (1) | CZ291281B6 (en) |
DE (1) | DE69431167T2 (en) |
HU (1) | HU221341B1 (en) |
NO (1) | NO962714L (en) |
NZ (1) | NZ278271A (en) |
PL (1) | PL182298B1 (en) |
RO (1) | RO117542B1 (en) |
RU (1) | RU2153885C2 (en) |
TJ (1) | TJ294B (en) |
WO (1) | WO1995017908A1 (en) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6461851B1 (en) | 1992-11-19 | 2002-10-08 | Anticancer, Inc. | High expression modules containing two or more tandem copies of a methioninase encoding sequence |
US5891704A (en) * | 1992-11-19 | 1999-04-06 | Anticancer, Inc. | Method to produce high levels of methioninase |
US6911309B2 (en) * | 1993-12-29 | 2005-06-28 | The Regents Of The University Of Californnia | Nucleic acids encoding MTAse |
US6870037B1 (en) * | 1995-07-03 | 2005-03-22 | Arch Development Corporation | Methylthioadenosine phosphorylase compositions and methods of use in the diagnosis and treatment of proliferative disorders |
US5861154A (en) * | 1995-10-30 | 1999-01-19 | Shionogi & Co., Ltd. | Recombinant L-methionine γ-lyase |
US7118903B2 (en) * | 2000-09-05 | 2006-10-10 | Shionogi & Co., Ltd. | L-methionine $g(g)-lyase with modified function |
WO2003020305A1 (en) * | 2001-08-30 | 2003-03-13 | Baylor College Of Medecine | Methionine restriction for cancer therapy |
AU2003261354A1 (en) * | 2002-08-02 | 2004-02-23 | The Regents Of The University Of California | New uses for inhibitors of inosine monophosphate dehydrogenase |
US7157551B2 (en) | 2003-02-14 | 2007-01-02 | Cephalon, Inc. | Compositions and methods for the detection and treatment of methylthioadenosine phosphorylase deficient cancers |
US20110002978A1 (en) * | 2003-06-17 | 2011-01-06 | Harrison Roger G | Enzyme prodrug cancer therapy selectively targeted to tumor cells or tumor vasculature and methods of production and use thereof |
EP2192905A4 (en) | 2007-08-29 | 2010-11-10 | Adam Lubin | Method for the selective therapy of disease |
WO2009140007A2 (en) * | 2008-04-14 | 2009-11-19 | Ats Medical, Inc. | Tool for implantation of replacement heart valve |
US9987241B2 (en) | 2014-09-25 | 2018-06-05 | The Board Of Regents Of The University Of Oklahoma | Enzyme conjugate and prodrug cancer therapy |
US11446365B2 (en) | 2017-08-09 | 2022-09-20 | The Board Of Regents Of The University Of Oklahoma | Antimalarial enzyme conjugates, kits containing same, and methods of producing and using same |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4179337A (en) * | 1973-07-20 | 1979-12-18 | Davis Frank F | Non-immunogenic polypeptides |
US5122614A (en) * | 1989-04-19 | 1992-06-16 | Enzon, Inc. | Active carbonates of polyalkylene oxides for modification of polypeptides |
-
1993
- 1993-12-29 US US08/176,413 patent/US5571510A/en not_active Expired - Fee Related
-
1994
- 1994-12-22 DE DE69431167T patent/DE69431167T2/en not_active Expired - Fee Related
- 1994-12-22 EP EP95906124A patent/EP0805690B1/en not_active Expired - Lifetime
- 1994-12-22 PL PL94315229A patent/PL182298B1/en unknown
- 1994-12-22 HU HU9601695A patent/HU221341B1/en not_active IP Right Cessation
- 1994-12-22 AT AT95906124T patent/ATE221785T1/en not_active IP Right Cessation
- 1994-12-22 CA CA002180262A patent/CA2180262A1/en not_active Abandoned
- 1994-12-22 CZ CZ19961869A patent/CZ291281B6/en not_active IP Right Cessation
- 1994-12-22 AU AU14459/95A patent/AU694161B2/en not_active Ceased
- 1994-12-22 RO RO96-01324A patent/RO117542B1/en unknown
- 1994-12-22 JP JP7518169A patent/JPH09507754A/en not_active Ceased
- 1994-12-22 TJ TJ96000320A patent/TJ294B/en unknown
- 1994-12-22 RU RU96116159/14A patent/RU2153885C2/en not_active IP Right Cessation
- 1994-12-22 NZ NZ278271A patent/NZ278271A/en unknown
- 1994-12-22 WO PCT/US1994/014919 patent/WO1995017908A1/en active IP Right Grant
- 1994-12-22 CN CN94195042A patent/CN1143325A/en active Pending
-
1996
- 1996-06-27 NO NO962714A patent/NO962714L/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
EP0805690B1 (en) | 2002-08-07 |
JPH09507754A (en) | 1997-08-12 |
ATE221785T1 (en) | 2002-08-15 |
CZ186996A3 (en) | 1996-12-11 |
AU1445995A (en) | 1995-07-17 |
RU2153885C2 (en) | 2000-08-10 |
HU221341B1 (en) | 2002-09-28 |
CN1143325A (en) | 1997-02-19 |
WO1995017908A1 (en) | 1995-07-06 |
DE69431167D1 (en) | 2002-09-12 |
CZ291281B6 (en) | 2003-01-15 |
US5571510A (en) | 1996-11-05 |
EP0805690A1 (en) | 1997-11-12 |
AU694161B2 (en) | 1998-07-16 |
PL182298B1 (en) | 2001-12-31 |
HUT75070A (en) | 1997-04-28 |
EP0805690A4 (en) | 1999-05-12 |
HU9601695D0 (en) | 1996-08-28 |
NO962714L (en) | 1996-08-26 |
DE69431167T2 (en) | 2003-04-17 |
NZ278271A (en) | 2001-07-27 |
RO117542B1 (en) | 2002-04-30 |
CA2180262A1 (en) | 1995-07-06 |
NO962714D0 (en) | 1996-06-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HU9601695D0 (en) | Method for selective methionine starvation of malignant cells in mammals | |
USD289896S (en) | Pocket telephone | |
GR3018029T3 (en) | New protein-polycation conjugates. | |
USD397085S (en) | Battery charger pocket | |
USD290605S (en) | Telephone set | |
AU2058088A (en) | Hybrid composite compressor | |
IT1238615B (en) | PROCEDURE FOR THE ENRICHMENT OF POWDERS, RESULTING IN THE CUBILOT, WITH METALLIC PARTICLES | |
USD314388S (en) | Endless track work vehicle | |
USD314566S (en) | Document holder for computer keyboard | |
AU558587B2 (en) | Antiinflammatory composition of inositol and piroxicam | |
USD301687S (en) | Mine roof support plate | |
USD292095S (en) | Handset telephone | |
USD293607S (en) | Nightlight | |
USD275377S (en) | Passenger rail vehicle | |
CA2037900A1 (en) | Pokeweed antiviral protein - monoclonal antibody conjugates | |
USD300743S (en) | Handset telephone with articulated end | |
USD271397S (en) | Articulated loader vehicle body | |
USD298429S (en) | Telephone stand with speakerphone | |
USD272748S (en) | Pocket insert for a notebook | |
USD324845S (en) | Passenger ferry superstructure | |
USD297839S (en) | Portable handset telephone or similar article | |
USD293104S (en) | Desk telephone set | |
USD280820S (en) | CRT work station | |
USD259571S (en) | Remote service conveyor unit | |
USD302270S (en) | Keyboard |